サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1537024

乳房生検市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年

Breast Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 353 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
乳房生検市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年
出版日: 2024年08月12日
発行: Persistence Market Research
ページ情報: 英文 353 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の乳房生検市場に関する詳細な調査レポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題など、重要な市場ダイナミクスを詳細に分析し、市場構造に関する包括的な洞察を提供しています。

主な洞察

  • 乳房生検の市場規模（2024E）：23億米ドル
  • 予測市場価値（2033F）：38億米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：5.7%

乳房生検市場- レポート範囲：

乳房生検市場には、検査のために小さな組織サンプルを採取して乳がんを診断するための様々な製品が含まれます。この市場には、がんの早期発見と診断に不可欠な針生検、開腹手術による生検、真空補助下生検など、さまざまなタイプの乳房生検が含まれます。この市場は、病院、診断センター、外来手術センターなど多様なセグメントにサービスを提供しており、直販や医療用品販売店など様々なチャネルを通じて流通しています。乳がん検診に対する意識の高まり、乳がんの有病率の上昇、生検技術の技術的進歩などが成長の原動力となっています。

市場成長の促進要因：

乳房生検の世界市場を牽引する要因はいくつかあります。世界の乳がん罹患率の上昇が乳房生検の需要を押し上げています。生検装置や手技の技術的進歩は、これらの手技の精度と快適性を高め、市場拡大に拍車をかけています。さらに、早期乳がん検診と診断に対する認識と取り組みの高まりが乳房生検の需要を後押ししています。ヘルスケア支出の増加と予防的健康対策への注目も市場拡大に寄与しています。

市場抑制要因：

有望な成長見込みがあるにもかかわらず、乳房生検市場は、高度な生検装置や手技の高コスト、不快感や感染リスクのような使用に伴う潜在的な問題に関連する課題に直面しています。市場はまた、医療機器の安全性に関する厳しい規制の存在や、進化する臨床ニーズに対応するための継続的な技術革新の必要性からも影響を受けています。これらの問題に対処し、競争力を維持するためには、効果的な患者教育、競争力のある価格設定、研究開発への継続的な投資が必要です。

市場機会：

市場開拓は、正確で快適な診断ソリューションに対する需要の高まりに対応するため、高品質で低侵襲な生検装置の開発に取り組んでいます。新興経済国におけるヘルスケア・インフラの拡大は、市場成長のための新たなチャネルを提供し、企業がより多くの人々にリーチすることを可能にします。都市化の進展と健康志向の高まりが乳房生検の需要を牽引しています。戦略的パートナーシップ、新技術への投資、革新的な生検装置のイントロダクションは、新たなビジネスチャンスを生かし、市場でのリーダーシップを維持するために不可欠です。

本レポートで扱う主な質問

  • 世界の乳房生検市場の成長を促進する主な要因は何か？
  • 乳房生検手技のどの種類と用途が様々な環境での採用をリードしているか？
  • 技術の進歩は乳房生検市場の競合情勢にどのような影響を与えているか？
  • 乳房生検市場の主要プレーヤーは誰で、競合を維持するためにどのような戦略をとっているのか？
  • 世界の乳房生検市場の新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と排除

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 付加価値の洞察

  • 製品の採用/使用状況分析
  • メーカー別の主なプロモーション戦略
  • 規制シナリオ
  • PESTLE分析
  • ポーターの分析
  • 新製品の発売
  • 技術評価

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別収益
    • 適応症別収益
    • エンドユーザー別収益
    • 国別収益
  • 2024年の市場シナリオ

第7章 世界市場の需要（数量）分析

  • 市場（数量）分析、2019～2023年
  • 市場（数量）予測、2024～2033年
    • 前年比成長動向分析

第8章 世界市場- 価格分析

  • 製品別の地域別価格分析
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク
  • 価格設定の前提

第9章 世界市場の需要（金額）分析

  • 市場（金額）分析、2019～2023年
  • 市場（金額）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第10章 製品別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額および数量）分析、2019～2023年
  • 市場規模（金額および数量）析と予測、2024～2033年
    • 生検針
      • コアニードル
      • 細吸引針
    • MRIガイド生検システム
    • 超音波ガイド下乳房生検システム
      • 2次元（2D）マンモグラフィ超音波スキャンシステム
      • 3次元（3D）Bモードマンモグラフィ超音波スキャンシステム
    • 吸引補助装置（VAD）
    • ガイドワイヤー（ローカリゼーションワイヤー）
    • 乳房生検マーカー
  • 製品別市場の魅力分析

第11章 適応症別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）析と予測、2024～2033年
    • 複雑嚢胞
    • 固体塊
    • 疑わしい固形腫瘤（線維腺腫）
    • 疑わしい微小石灰化
  • 適応症別の市場の魅力分析

第12章 エンドユーザー別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）析と予測、2024～2033年
    • 病院
    • 専門クリニック
    • 外来手術センター
    • がん調査機関
  • エンドユーザー別市場の魅力分析

第13章 地域別：世界市場分析

  • イントロダクション
  • 市場規模（金額および数量）分析、2019～2023年
  • 市場規模（金額および数量）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ（中東・アフリカ）
  • 地域別市場の魅力分析

第14章 北米市場分析

第15章 ラテンアメリカ市場分析

第16章 欧州市場分析

第17章 南アジア市場分析

第18章 東アジア市場分析

第19章 オセアニア市場分析

第20章 中東・アフリカ市場分析

第21章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析（%）
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 主要プレーヤーによるブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細
    • Argon Medical Devices
    • Becton Dickinson and Company
    • CR Bard, Inc.
    • Cook Medical Inc.
    • Devicor Medical Products, Inc.
    • F. Hoffmann-La Roche Ltd.
    • GE Healthcare
    • Hologic, Inc.
    • Leica Biosystems
    • Medax Srl Unipersonale
    • Planmed Oy
    • Scion Medical Technologies, LLC
    • Siemens Healthineer

第23章 使用される前提条件と頭字語

第24章 調査手法

目次
Product Code: PMRREP33464

Persistence Market Research has recently published a detailed report on the global Breast Biopsy Market. This report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing comprehensive insights into the market structure.

Key Insights:

  • Breast Biopsy Market Size (2024E): USD 2.3 Bn
  • Projected Market Value (2033F): USD 3.8 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.7%

Breast Biopsy Market - Report Scope:

The Breast Biopsy Market encompasses a variety of products designed to diagnose breast cancer by removing a small tissue sample for examination. This market includes different types of breast biopsy procedures, such as needle biopsy, open surgical biopsy, and vacuum-assisted biopsy, which are essential for early cancer detection and diagnosis. The market serves diverse segments, including hospitals, diagnostic centers, and ambulatory surgical centers, distributed through various channels like direct sales and medical supply distributors. Growth is driven by increasing awareness of breast cancer screening, rising prevalence of breast cancer, and technological advancements in biopsy techniques.

Market Growth Drivers:

Several key factors drive the global Breast Biopsy Market. The rising incidence of breast cancer globally boosts the demand for breast biopsy procedures. Technological advancements in biopsy devices and techniques enhance the accuracy and comfort of these procedures, fueling market expansion. Additionally, the growing awareness and initiatives for early breast cancer screening and diagnosis drive the demand for breast biopsy. Increased healthcare expenditure and a focus on preventive health measures also contribute to market growth.

Market Restraints:

Despite promising growth prospects, the Breast Biopsy Market faces challenges related to the high cost of advanced biopsy devices and procedures and potential issues associated with their use, such as discomfort and risk of infection. The market is also impacted by the presence of stringent regulations on medical device safety and the need for continuous innovation to meet evolving clinical needs. Effective patient education, competitive pricing, and ongoing investment in research and development are necessary to address these issues and maintain a competitive edge.

Market Opportunities:

The market presents significant opportunities driven by the rising trend of early cancer detection and increasing awareness about the benefits of breast cancer screening.The development of high-quality and minimally invasive biopsy devices caters to the growing demand for accurate and comfortable diagnostic solutions. The expansion of healthcare infrastructure in emerging economies provides new channels for market growth, allowing companies to reach a broader audience. Increasing urbanization and the rising number of health-conscious individuals drive the demand for breast biopsy procedures. Strategic partnerships, investments in new technologies, and the introduction of innovative biopsy devices are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Breast Biopsy Market globally?
  • Which types and applications of breast biopsy procedures are leading the adoption in various settings?
  • How are technological advancements influencing the competitive landscape of the Breast Biopsy Market?
  • Who are the key players in the Breast Biopsy Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Breast Biopsy Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Biopsy Market, including Hologic, Inc., Becton, Dickinson and Company, and Leica Biosystems, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced biopsy devices and techniques, such as vacuum-assisted and stereotactic biopsy systems. Collaborations with healthcare providers, research institutions, and medical device distributors facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Breast Biopsy Market landscape.

Key Companies Profiled:

  • Argon Medical
  • Becton Dickinson and Company
  • C.R. Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.,
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy
  • Scion Medical Technologies, LLC
  • Siemens Healthineers
  • Hikma Pharmaceuticals
  • Incytes

Breast Biopsy Market Industry Segmentation

By Product:

  • Biopsy Needles
  • MRI-Guide Biopsy Systems
  • Ultrasound Guided Breast Biopsy Systems
  • Vacuum-Assisted Devices (VAD)
  • Guide Wire (Localization Wire)
  • Breast Biopsy Markers

Indication:

  • Complex Cysts
  • Solid Mass
  • Suspicious Solid Mass (Fibroadenoma)
  • Suspicious Micro-calcifications

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusion

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value Added Insights

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Key Promotional Strategies, by Manufacturers
  • 4.3. Regulatory Scenario
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. New Product Launches
  • 4.7. Technology Assessment

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising demand for Breast Biopsy Devices
    • 5.2.2. Cost of Procedures
    • 5.2.3. Adoption Rate
    • 5.2.4. Increase in Research and Development
    • 5.2.5. Availability of Product
    • 5.2.6. Strategic Mergers and Collaborations Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue by Product
    • 6.1.2. Revenue By Indication
    • 6.1.3. Revenue By End User
    • 6.1.4. Revenue By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Volume Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis by Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) & Volume (Units) Analysis by Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. Biopsy Needle
      • 10.3.1.1. Core Needles
      • 10.3.1.2. Fine Aspiration Needles
    • 10.3.2. MRI-Guide Biopsy Systems
    • 10.3.3. Ultrasound Guided Breast Biopsy Systems
      • 10.3.3.1. Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
      • 10.3.3.2. Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 10.3.4. Vacuum-Assisted Device (VAD)
    • 10.3.5. Guide Wire (Localization Wire)
    • 10.3.6. Breast Biopsy Marker
  • 10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis by Indication, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
    • 11.3.1. Complex Cyst
    • 11.3.2. Solid Mass
    • 11.3.3. Suspicious Solid Mass (Fibroadenoma)
    • 11.3.4. Suspicious Micro Calcifications
  • 11.4. Market Attractiveness Analysis by Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Specialty Clinics
    • 12.3.3. Ambulatory Surgical Centers
    • 12.3.4. Cancer Research Institutes
  • 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East & Africa(MEA)
  • 13.4. Market Attractiveness Analysis by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By End User
    • 14.8.2. Canada Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By End-User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast recast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Brazil Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By End User
    • 15.8.2. Mexico Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By End User
    • 15.8.3. Argentina Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Nordic Countries
      • 16.3.1.8. Russia
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By End User
    • 16.8.2. Italy Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By End User
    • 16.8.3. France Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By End User
    • 16.8.4. U.K. Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Indication
        • 16.8.4.2.3. By End User
    • 16.8.5. Spain Market
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Indication
        • 16.8.5.2.3. By End User
    • 16.8.6. BENELUX Market
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Indication
        • 16.8.6.2.3. By End User
    • 16.8.7. Nordic Countries Market
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Indication
        • 16.8.7.2.3. By End User
    • 16.8.8. Russia Market
      • 16.8.8.1. Introduction
      • 16.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.8.2.1. By Product
        • 16.8.8.2.2. By Indication
        • 16.8.8.2.3. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By End User
    • 17.8.2. Thailand Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By End User
    • 17.8.3. Indonesia Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Indication
        • 17.8.3.2.3. By End User
    • 17.8.4. Malaysia Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Indication
        • 17.8.4.2.3. By End User

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. China Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By End User
    • 18.8.2. Japan Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By End User
    • 18.8.3. South Korea Market
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By End User

19. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Indication
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Indication
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Market
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Indication
        • 19.8.1.2.3. By End User
    • 19.8.2. New Zealand Market
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Indication
        • 19.8.2.2.3. By End User

20. Middle East & Africa Market Analysis 2019-2023and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. North Africa
      • 20.3.1.5. Rest of MEA
    • 20.3.2. By Product
    • 20.3.3. By Indication
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Indication
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Market
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Indication
        • 20.8.1.2.3. By End User
    • 20.8.2. Turkiye Market
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Indication
        • 20.8.2.2.3. By End User
    • 20.8.3. South Africa Market
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Indication
        • 20.8.3.2.3. By End User
    • 20.8.4. North Africa Market
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Indication
        • 20.8.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players (%)
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Branding and Promotional Strategies, by Key Players
  • 22.3. Key Development Analysis
  • 22.4. Competition Deep Dive
    • 22.4.1. Argon Medical Devices
      • 22.4.1.1. Overview
      • 22.4.1.2. Product Portfolio
      • 22.4.1.3. Key Financial
      • 22.4.1.4. Sales Footprint
      • 22.4.1.5. SWOT Analysis
      • 22.4.1.6. Strategy Overview
        • 22.4.1.6.1. Marketing Strategies
        • 22.4.1.6.2. Product Strategies
        • 22.4.1.6.3. Channel Strategies
    • 22.4.2. Becton Dickinson and Company
      • 22.4.2.1. Overview
      • 22.4.2.2. Product Portfolio
      • 22.4.2.3. Key Financial
      • 22.4.2.4. Sales Footprint
      • 22.4.2.5. SWOT Analysis
      • 22.4.2.6. Strategy Overview
        • 22.4.2.6.1. Marketing Strategies
        • 22.4.2.6.2. Product Strategies
        • 22.4.2.6.3. Channel Strategies
    • 22.4.3. C. R. Bard, Inc.
      • 22.4.3.1. Overview
      • 22.4.3.2. Product Portfolio
      • 22.4.3.3. Key Financial
      • 22.4.3.4. Sales Footprint
      • 22.4.3.5. SWOT Analysis
      • 22.4.3.6. Strategy Overview
        • 22.4.3.6.1. Marketing Strategies
        • 22.4.3.6.2. Product Strategies
        • 22.4.3.6.3. Channel Strategies
    • 22.4.4. Cook Medical Inc.
      • 22.4.4.1. Overview
      • 22.4.4.2. Product Portfolio
      • 22.4.4.3. Key Financial
      • 22.4.4.4. Sales Footprint
      • 22.4.4.5. SWOT Analysis
      • 22.4.4.6. Strategy Overview
        • 22.4.4.6.1. Marketing Strategies
        • 22.4.4.6.2. Product Strategies
        • 22.4.4.6.3. Channel Strategies
    • 22.4.5. Devicor Medical Products, Inc.
      • 22.4.5.1. Overview
      • 22.4.5.2. Product Portfolio
      • 22.4.5.3. Key Financial
      • 22.4.5.4. Sales Footprint
      • 22.4.5.5. SWOT Analysis
      • 22.4.5.6. Strategy Overview
        • 22.4.5.6.1. Marketing Strategies
        • 22.4.5.6.2. Product Strategies
        • 22.4.5.6.3. Channel Strategies
    • 22.4.6. F. Hoffmann-La Roche Ltd.
      • 22.4.6.1. Overview
      • 22.4.6.2. Product Portfolio
      • 22.4.6.3. Key Financial
      • 22.4.6.4. Sales Footprint
      • 22.4.6.5. SWOT Analysis
      • 22.4.6.6. Strategy Overview
        • 22.4.6.6.1. Marketing Strategies
        • 22.4.6.6.2. Product Strategies
        • 22.4.6.6.3. Channel Strategies
    • 22.4.7. GE Healthcare
      • 22.4.7.1. Overview
      • 22.4.7.2. Product Portfolio
      • 22.4.7.3. Key Financial
      • 22.4.7.4. Sales Footprint
      • 22.4.7.5. SWOT Analysis
      • 22.4.7.6. Strategy Overview
        • 22.4.7.6.1. Marketing Strategies
        • 22.4.7.6.2. Product Strategies
        • 22.4.7.6.3. Channel Strategies
    • 22.4.8. Hologic, Inc.
      • 22.4.8.1. Overview
      • 22.4.8.2. Product Portfolio
      • 22.4.8.3. Key Financial
      • 22.4.8.4. Sales Footprint
      • 22.4.8.5. SWOT Analysis
      • 22.4.8.6. Strategy Overview
        • 22.4.8.6.1. Marketing Strategies
        • 22.4.8.6.2. Product Strategies
        • 22.4.8.6.3. Channel Strategies
    • 22.4.9. Leica Biosystems
      • 22.4.9.1. Overview
      • 22.4.9.2. Product Portfolio
      • 22.4.9.3. Key Financial
      • 22.4.9.4. Sales Footprint
      • 22.4.9.5. SWOT Analysis
      • 22.4.9.6. Strategy Overview
        • 22.4.9.6.1. Marketing Strategies
        • 22.4.9.6.2. Product Strategies
        • 22.4.9.6.3. Channel Strategies
    • 22.4.10. Medax Srl Unipersonale
      • 22.4.10.1. Overview
      • 22.4.10.2. Product Portfolio
      • 22.4.10.3. Key Financial
      • 22.4.10.4. Sales Footprint
      • 22.4.10.5. SWOT Analysis
      • 22.4.10.6. Strategy Overview
        • 22.4.10.6.1. Marketing Strategies
        • 22.4.10.6.2. Product Strategies
        • 22.4.10.6.3. Channel Strategies
    • 22.4.11. Planmed Oy
      • 22.4.11.1. Overview
      • 22.4.11.2. Product Portfolio
      • 22.4.11.3. Key Financial
      • 22.4.11.4. Sales Footprint
      • 22.4.11.5. SWOT Analysis
      • 22.4.11.6. Strategy Overview
        • 22.4.11.6.1. Marketing Strategies
        • 22.4.11.6.2. Product Strategies
        • 22.4.11.6.3. Channel Strategies
    • 22.4.12. Scion Medical Technologies, LLC
      • 22.4.12.1. Overview
      • 22.4.12.2. Product Portfolio
      • 22.4.12.3. Key Financial
      • 22.4.12.4. Sales Footprint
      • 22.4.12.5. SWOT Analysis
      • 22.4.12.6. Strategy Overview
        • 22.4.12.6.1. Marketing Strategies
        • 22.4.12.6.2. Product Strategies
        • 22.4.12.6.3. Channel Strategies
    • 22.4.13. Siemens Healthineer
      • 22.4.13.1. Overview
      • 22.4.13.2. Product Portfolio
      • 22.4.13.3. Key Financial
      • 22.4.13.4. Sales Footprint
      • 22.4.13.5. SWOT Analysis
      • 22.4.13.6. Strategy Overview
        • 22.4.13.6.1. Marketing Strategies
        • 22.4.13.6.2. Product Strategies
        • 22.4.13.6.3. Channel Strategies

23. Assumptions and Acronyms Used

24. Research Methodology